Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) EBIT Margin (2016 - 2018)

Historic EBIT Margin for ENDRA Life Sciences (NDRA) over the last 3 years, with Q1 2018 value amounting to 45960.77%.

  • ENDRA Life Sciences' EBIT Margin changed N/A to 45960.77% in Q1 2018 from the same period last year, while for Dec 2018 it was 146080.47%, marking a year-over-year decrease of 1447651200.0%. This contributed to the annual value of 9971.19% for FY2024, which is 76864800.0% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported EBIT Margin of 45960.77% as of Q1 2018.
  • In the past 5 years, ENDRA Life Sciences' EBIT Margin registered a high of 210.52% during Q2 2016, and its lowest value of 45960.77% during Q1 2018.
  • Its 3-year average for EBIT Margin is 13580.91%, with a median of 1073.38% in 2017.
  • The largest annual percentage gain for ENDRA Life Sciences' EBIT Margin in the last 5 years was -20398800bps (2017), contrasted with its biggest fall of -334647400bps (2017).
  • Over the past 3 years, ENDRA Life Sciences' EBIT Margin (Quarter) stood at 61.85% in 2016, then plummeted by -54107bps to 33526.58% in 2017, then tumbled by -37bps to 45960.77% in 2018.
  • Its EBIT Margin stands at 45960.77% for Q1 2018, versus 33526.58% for Q4 2017 and 317.4% for Q3 2017.